Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' DAVER A' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 28 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Broet, P; Romain, S; Daver, A; Ricolleau, G; Quillien, V; Rallet, A; Asselain, B; Martin, PM; Spyratos, F
      Thymidine kinase as a proliferative marker: Clinical relevance in 1,692 primary breast cancer patients

      JOURNAL OF CLINICAL ONCOLOGY
    2. Pichon, MF; Basuyau, JP; Gory-Delabaere, G; Eche, N; Daver, A; Blanc-Vincent, MP; Riedinger, JM; Deneux, L; Bidart, JM
      Standards, Options and Recommendations for tumor markers in thyroid cancers

      BULLETIN DU CANCER
    3. Chautard, D; Bocquillon, V; Daver, A; Colls, P; Soret, JY
      Is it possible to define a cut-off value for the free PSA index that is useful in routine urological practice?

      PROGRES EN UROLOGIE
    4. Uhrhammer, N; Bay, JO; Gosse-Brun, S; Kwiatkowski, F; Rio, P; Daver, A; Bignon, YJ
      Allelic imbalance at NBS1 is frequent in both proximal and distal colorectal carcinoma

      ONCOLOGY REPORTS
    5. Chautard, D; Daver, A; Bocquillon, V; Verriele, V; Colls, P; Bertrand, G; Soret, JY
      Comparison of the bard Trak (TM) test with voided urine cytology in the diagnosis and follow-up of bladder tumors

      EUROPEAN UROLOGY
    6. Romain, S; Spyratos, F; Descotes, F; Daver, A; Rostaing-Puissant, B; Bougnoux, P; Colonna, M; Bolla, M; Martin, PM
      Prognostic of DNA-synthesizing enzyme activities (thymidine kinase and thymidylate synthase) in 908 T1-T2, N0-N1, M0 breast cancers: A retrospective multicenter study

      INTERNATIONAL JOURNAL OF CANCER
    7. Basuyau, JP; Blanc-Vincent, MP; Bidart, JM; Daver, A; Deneux, L; Eche, N; Gory-Delabaere, G; Pichon, MF; Riedinger, JM
      Standards, Options and Recommendations (SOR) for tumor markers in breast cancer

      BULLETIN DU CANCER
    8. Bernard, MH; Massart, C; Werneau, JL; Schlienger, JL; Mlika-Cabanne, N; Blouin, P; Bukowski, JV; Chupin, M; Collignon, I; De Boysson, M; Isnard, R; Jamet, JL; Kaloustian, E; Mas, JL; Massart, C; Mira, R; Rohmer, V; Rousset, H; Soulie, P; Teslar, E; Mlika-Cabanne, N; Alix, M; Archambeaud, F; Aubert, L; Baldet, L; Beutter, D; Caron, P; Chabrier, G; Chantegreil, F; Chapuis, J; Cohen-Solal, A; Conte-Devoix, B; Couplet, G; Dany, F; Daver, A; Doucet, J; Dreyfus, M; Du Rostu, H; Gay, B; Giraud, P; Gruson, A; Gerber, F; Guillausseau, C; Houlbert, C; Kahn, R; Lagarde, J; Laisne, C; Legrand, JL; Leveque, M; Martinet, C; Millet, A; Nambotin, P; Orgiazzi, J; Pochet, P; Potier, A; Pouget-Abadie, JF; Rouanet, G; Rymer, JC; Sadoul, JL; Sapin, R; Tardieu, J; Thibon, R; Vetel, JM; Wemeau, JL; Winiszewski, P
      Laboratory diagnosis and follow-up of adults with hyperthyroidism

      ANNALES D ENDOCRINOLOGIE
    9. Uhrhammer, N; Bay, JO; Pernin, D; Rio, P; Grancho, M; Kwiatkowski, F; Gosse-Brun, S; Daver, A; Bignon, YJ
      Loss of heterozygosity at the ATM locus in colorectal carcinoma

      ONCOLOGY REPORTS
    10. Chautard, D; Daver, A; Mermod, B; Tichet, A; Bocquillon, V; Soret, JY
      Va lues for the free to total prostate-specific antigen ratio as a function of age: Necessity of reference range validation

      EUROPEAN UROLOGY
    11. Dalifard, I; Daver, A; Larra, F
      Cytosolic p53 protein and serum p53 autoantibody evaluation in breast cancer. Comparison with prognostic factors

      ANTICANCER RESEARCH
    12. Gosse-Brun, S; Sauvaigo, S; Daver, A; Page, M; Lortholary, A; Larra, F; Bignon, YJ; Bernard-Gallon, D
      Specific H-ras minisatellite alleles in breast cancer susceptibility

      ANTICANCER RESEARCH
    13. Rymer, JC; Sabatier, R; Daver, A; Bourleaud, J; Assicot, M; Bremond, J; Rapin, J; Salhi, SL; Thinion, B; Vassault, A; Ingrand, J; Pau, B
      A new approach for clinical biological assay comparison and standardization: Application of principal component analysis to a multicenter study of twenty-one carcinoembryonic antigen immunoassay kits

      CLINICAL CHEMISTRY
    14. Bidart, JM; Thuillier, F; Augereau, C; Chalas, J; Daver, A; Jacob, N; Labrousse, F; Voitot, H
      Kinetics of serum tumor marker concentrations and usefulness in clinical monitoring

      CLINICAL CHEMISTRY
    15. Spyratos, F; Romain, S; Rostaing-Puissant, B; Daver, A; Colonna, M; Descotes, F; Martin, PM; Bougnoux, P; Roth, H; Bolla, M
      Standardization and quality control in the evaluation of proliferation parameters in T1T2, N0N1, M0 breast cancer: multicentric retrospective study 1. DNA synthesis enzyme activities

      BULLETIN DU CANCER
    16. Broet, P; Spyratos, F; Romain, S; Quillien, V; Daver, A; Ricolleau, G; Rallet, A; Toulas, C; Asselain, B
      Prognostic value of uPA and p53 accumulation measured by quantitative biochemical assays in 1245 primary breast cancer patients: a multicentre study

      BRITISH JOURNAL OF CANCER
    17. DALIFARD I; DAVER A; GOUSSARD J; LORIMIER G; GOSSEBRUN S; LORTHOLARY A; LARRA F
      P185 OVEREXPRESSION IN 220 SAMPLES OF BREAST-CANCER UNDERGOING PRIMARY SURGERY - COMPARISON WITH C-ERBB-2 GENE AMPLIFICATION

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    18. KOSCIELNY S; TERRIER P; DAVER A; WAFFLART J; GOUSSARD J; RICOLLEAU G; DELVINCOURT C; DELARUE JC
      QUANTITATIVE-DETERMINATION OF C-ERBB-2 IN HUMAN BREAST-TUMORS - POTENTIAL PROGNOSTIC-SIGNIFICANCE OF LOW VALUES

      European journal of cancer
    19. GOSSEBRUN S; SAUVAIGO S; DAVER A; LARRA F; KWIATKOWSKI F; BIGNON YJ; BERNARDGALLON D
      ASSOCIATION BETWEEN H-RAS MINISATELLITE AND COLORECTAL-CANCER RISK

      Anticancer research
    20. MURATET JP; DAVER A; MINIER JF; LARRA F
      INFLUENCE OF SCANNING DOSES OF I-131 ON SUBSEQUENT FIRST ABLATIVE TREATMENT OUTCOME IN PATIENTS OPERATED ON FOR DIFFERENTIATED THYROID-CARCINOMA

      The Journal of nuclear medicine
    21. GOSSE S; SAUVAIGO S; DAVER A; LARRA F; SAAVEDRA J; MARCHAND J; BERNARDGALLON D; BIGNON YJ
      EVALUATION OF THE AUTOMATED FLUORESCENT ANALYSIS OF THE H-RAS MINISATELLITE AFTER OPTIMIZED PCR AMPLIFICATION IN COMPARISON WITH A STANDARDIZED SOUTHERN BLOT TECHNIQUE

      International journal of oncology
    22. PAINBENI T; GAMELIN E; CAILLEUX A; LEBOUIL A; BOISDRONCELLE M; DAVER A; LARRA F; ALLAIN P
      PLASMA SIALIC-ACID AS A MARKER OF THE EFFECT OF THE TREATMENT ON METASTATIC COLORECTAL-CANCER

      European journal of cancer
    23. MURATET JP; GIRAUD P; DAVER A; MINIER JF; GAMELIN E; LARRA F
      PREDICTING THE EFFICACY OF FIRST I-131 TREATMENT IN DIFFERENTIATED THYROID-CARCINOMA

      The Journal of nuclear medicine
    24. MURATET JP; GIRAUD P; DAVER A; MINIER JF; LARRA F
      DO SCANNING DOSES OF I-131 STUN THYROID REMNANTS - A COMPARISON OF 37VS 111 MBQ BEFORE FIRST I-131 ABLATIVE THERAPY IN PATIENTS WITH DIFFERENTIATED THYROID-CARCINOMA

      The Journal of nuclear medicine
    25. MARQUET PY; DAVER A; SAPIN R; BRIDGI B; MURATET JP; HARTMANN DJ; PAOLUCCI F; PAU B
      HIGHLY SENSITIVE IMMUNORADIOMETRIC ASSAY FOR SERUM THYROGLOBULIN WITHMINIMAL INTERFERENCE FROM AUTOANTIBODIES

      Clinical chemistry
    26. LARBRE H; THEOBALD S; DAVER A; SAUVAN R; WAFFLART J; RICOLLEAU G; GOUSSARD J; AUVRAY E; GOSSELIN P; BASUYAU JP; ANGIBEAU RM
      RECEIVER OPERATING CHARACTERISTIC (ROC) CURVE ANALYSIS OF THE TUMOR-MARKERS CEA, CA-19.9 AND CA-195 IN GASTROINTESTINAL CANCERS - RESULTS FROM A RETROSPECTIVE FRENCH MULTICENTER EVALUATION

      Journal of tumor marker oncology
    27. MOYRETLALLE C; MARCAIS C; JACQUEMIER J; MOLES JP; DAVER A; SORET JY; JEANTEUR P; OZTURK M; THEILLET C
      RAS, P53 AND HPV STATUS IN BENIGN AND MALIGNANT PROSTATE TUMORS

      International journal of cancer
    28. BESSE G; KWIATKOWSKI F; GAILLARD G; DAVER A; DALIFARD I; BASUYAU JP; BRUNELLE P; WAFFLART J; ANGIBEAU RM; AUVRAY E; GOUSSARD J
      PS2 PROTEIN AS PROGNOSTIC FACTOR IN 1065 CASES OF HUMAN BREAST-CANCER- A MULTICENTRIC STUDY

      Bulletin du cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/10/20 alle ore 23:08:46